GFAP and Alzheimer disease: On the other hand, the risk of developing non‐AD increased with higher plasma levels of GFAP and NfL, similar to the association with all‐cause dementia, but no clear association was found between plasma levels of Aβ42/40 or p‐τ181 and the risk of non‐AD (Figs 1 and 2).